Zacks Investment Research on MSN

Gilead (GILD) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, Gilead Sciences (GILD) reported revenue of $7.77 billion, up 3% over the same period last year. EPS came in at $2.47, compared to $2.02 in the year-ago quarter.
Investor's Business Daily on MSN

Gilead Stock Reverses; Why Its Buy-Side Miss Isn't The End For Its New HIV Shot

Gilead stock reversed higher on smaller losses Friday as analysts noted encouraging indicators for its newly approved HIV ...